retatrutide fatty liver study Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a trial retatrutide nonalcoholic fatty liver disease
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




















